Telmisartan (CAS 144701-48-4) ARB Antihypertensive API

Telmisartan (CAS 144701-48-4) is a high-purity ARB antihypertensive API with a targeted cardiovascular regulatory mechanism. It selectively blocks the binding of angiotensin Ⅱ to AT1 receptors, dilating peripheral blood vessels and reducing blood pressure without affecting bradykinin metabolism, while providing protective effects on the heart and kidneys. Its refined crystalline form ensures consistent bioactivity and low impurity profiles, making it a reliable active ingredient for cardiovascular pharmaceutical R&D.

Tailored for pharmaceutical manufacturers and cardiology research institutions, this product adheres to strict international quality and regulatory standards. It addresses the core demand for long-acting antihypertensive raw materials, supporting the development of formulations for essential hypertension and diabetic nephropathy research. Its stable chemical structure guarantees extended shelf life, facilitating flexible formulation design for oral preparations and clinical trial applications.